JNCE
Morgan Stanley’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-119,925
| Closed | -$222K | – | 7800 |
|
|
2023
Q1 | $222K | Sell |
119,925
-1,538,000
| -93% | -$2.85M | ﹤0.01% | 5667 |
|
|
2022
Q4 | $1.84M | Sell |
1,657,925
-20,523
| -1% | -$22.8K | ﹤0.01% | 4520 |
|
|
2022
Q3 | $3.93M | Buy |
1,678,448
+48,526
| +3% | +$114K | ﹤0.01% | 3892 |
|
|
2022
Q2 | $4.94M | Buy |
1,629,922
+103,634
| +7% | +$314K | ﹤0.01% | 3783 |
|
|
2022
Q1 | $10.4M | Buy |
1,526,288
+1,490,895
| +4,212% | +$10.1M | ﹤0.01% | 2867 |
|
|
2021
Q4 | $295K | Buy |
35,393
+11,688
| +49% | +$97.4K | ﹤0.01% | 5852 |
|
|
2021
Q3 | $175K | Sell |
23,705
-67,026
| -74% | -$495K | ﹤0.01% | 6071 |
|
|
2021
Q2 | $617K | Buy |
90,731
+73,775
| +435% | +$502K | ﹤0.01% | 5391 |
|
|
2021
Q1 | $174K | Sell |
16,956
-17,773
| -51% | -$182K | ﹤0.01% | 5738 |
|
|
2020
Q4 | $243K | Buy |
34,729
+730
| +2% | +$5.11K | ﹤0.01% | 5495 |
|
|
2020
Q3 | $278K | Buy |
33,999
+9,671
| +40% | +$79.1K | ﹤0.01% | 4937 |
|
|
2020
Q2 | $168K | Sell |
24,328
-19,930
| -45% | -$138K | ﹤0.01% | 5157 |
|
|
2020
Q1 | $210K | Sell |
44,258
-3,102
| -7% | -$14.7K | ﹤0.01% | 4844 |
|
|
2019
Q4 | $414K | Buy |
47,360
+1,627
| +4% | +$14.2K | ﹤0.01% | 5039 |
|
|
2019
Q3 | $152K | Buy |
45,733
+31,083
| +212% | +$103K | ﹤0.01% | 5273 |
|
|
2019
Q2 | $72K | Sell |
14,650
-1,512
| -9% | -$7.43K | ﹤0.01% | 5465 |
|
|
2019
Q1 | $101K | Sell |
16,162
-103,594
| -87% | -$647K | ﹤0.01% | 5387 |
|
|
2018
Q4 | $403K | Buy |
119,756
+71,003
| +146% | +$239K | ﹤0.01% | 4925 |
|
|
2018
Q3 | $317K | Sell |
48,753
-70,772
| -59% | -$460K | ﹤0.01% | 5241 |
|
|
2018
Q2 | $915K | Buy |
119,525
+81,518
| +214% | +$624K | ﹤0.01% | 4682 |
|
|
2018
Q1 | $849K | Sell |
38,007
-9,683
| -20% | -$216K | ﹤0.01% | 4658 |
|
|
2017
Q4 | $607K | Sell |
47,690
-48,231
| -50% | -$614K | ﹤0.01% | 4862 |
|
|
2017
Q3 | $1.49M | Buy |
95,921
+83,561
| +676% | +$1.3M | ﹤0.01% | 4138 |
|
|
2017
Q2 | $174K | Sell |
12,360
-249
| -2% | -$3.51K | ﹤0.01% | 5405 |
|
|
2017
Q1 | $278K | Buy |
+12,609
| New | +$278K | ﹤0.01% | 5157 |
|